Cannabis Use Disorder Treatment Study

December 7, 2022 updated by: Michael Mason, The University of Tennessee, Knoxville

Treating Young Adult Cannabis Use Disorder With Text Message-Delivered Peer Network Counseling

The purpose of this study is to test a text-delivered counseling program to stop or reduce cannabis use among young adults (ages 18 to 25).

Study Overview

Detailed Description

After being informed about the study and potential risks, participants will complete online screening assessments. Those who are determined to be eligible via online screening will complete a urine drug screen to confirm eligibility. Once eligibility is confirmed, participants will be randomized either to the intervention group or to the wait-list control group. Those who are randomized to the intervention group will receive the 4-week text intervention via smartphone and complete assessments (including urine drug screens) at baseline, 1 month, 3 months, and 6 months. Those who are randomized to the wait-list control group will only complete the assessments (including urine drug screens) at baseline, 1 month, 3 months, and 6 months. Participants who are initially assigned to the wait-list control group can choose to receive the text intervention once their 6-month participation is complete.

Study Type

Interventional

Enrollment (Actual)

1077

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Fort Collins, Colorado, United States, 80523
        • Colorado State University
    • Tennessee
      • Knoxville, Tennessee, United States, 37996
        • University of Tennessee Knoxvile

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. 18 to 25 years old.
  2. use of cannabis three or more days during a typical week.
  3. a score of at least eight on the Cannabis Use Disorder Identification Test-Revised
  4. a urine specimen positive for cannabis metabolites.
  5. a score of at least two on the Mini International Neuropsychiatric Interview: Version 7.0.2 for DSM-V, Substance Use Disorder
  6. must live in Tennessee or Colorado

Exclusion Criteria:

  1. substance abuse treatment during the past three months.
  2. lack of access to a text-capable phone.
  3. unable or unwilling to commit to six months of follow-up.
  4. not fluent in English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Participants randomized to the Intervention group will complete questionnaires at baseline, 1 month, 3 months, and 6 months and will receive 4 weeks of the PNC-txt intervention.
4-week text counseling program
Other Names:
  • PNC-txt
No Intervention: Waitlist Control
Participants randomized to the waitlist control group will complete questionnaires at baseline, 1 month, 3 months, and 6 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Tetrahydrocannabinol (Delta-9-THC-COOH) levels
Time Frame: Baseline, 1 month, 3 months, 6 months
Urine THC levels (50ng/mL, 100ng/mL, 200ng/mL, 300ng/mL) will provide a biological measure for current cannabis use.
Baseline, 1 month, 3 months, 6 months
Change in Past 30-Day Cannabis Use
Time Frame: Baseline, 1 month, 3 months, 6 months
Past-30-day substance use (cannabis, alcohol, tobacco, other drugs) and consequences are measured using the Alcohol, Smoking and Substance Involvement Screening Test
Baseline, 1 month, 3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Environmental Risk Assessment
Time Frame: Baseline, 1 month, 3 months, 6 months
Participants will report using the Ecological Momentary Assessment reporting about Craving (0=none-10= intense), Cannabis Use (0=none-10= a lot), Mood (0=very good-10= very depressed), and Stress (0=no stress-10 = very stressed) on a 10 point scale for each item
Baseline, 1 month, 3 months, 6 months
Change in Young Adult Social Network Assessment
Time Frame: Baseline, 1 month, 3 months, 6 months
Participants report information on each their 3 closest friends, representing their egocentric network. Individual friend scores are totaled based on all 8 risky and prosocial items (2-9). Thus, each peer's score has a potential range from -32 to 32, with greater scores indicating a healthier relationship. The total peer network health scores is based on the sum of all 24 risky and prosocial items across all three friends. Assuming three peers per participant, total network quality scores may range from -96 to 96, with lower scores indicating greater network risk and higher scores indicating greater network protection.
Baseline, 1 month, 3 months, 6 months
Cost Measures
Time Frame: 6 months
Cost of intervention implementation will be compared to typical treatment cost for cannabis use disorder
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael J Mason, Ph.D., University of Tennessee, Knoxville
  • Principal Investigator: J. Douglas Coatsworth, Ph.D., University of Tennessee, Knoxville

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 7, 2020

Primary Completion (Anticipated)

May 31, 2024

Study Completion (Anticipated)

June 30, 2024

Study Registration Dates

First Submitted

September 21, 2020

First Submitted That Met QC Criteria

September 21, 2020

First Posted (Actual)

September 28, 2020

Study Record Updates

Last Update Posted (Estimate)

December 8, 2022

Last Update Submitted That Met QC Criteria

December 7, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 1R01DA044206-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cannabis Use Disorder, Mild

Clinical Trials on Peer Network Counseling-txt

3
Subscribe